– Henter JI, Horne A, Arico M, Egeler RM, Filipovich AH, Imashuku S, et al. HLH-2004: diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis. Pediatr Blood Cancer. 2007;48:124–31.
– Ramos-Casals M, Brito-Zerón P, López-Guillermo A, Khamashta MA, Bosch X. Adult haemophagocytic syndrome. The Lancet. 2014;383(9927):1503–16.
– Rivière S, Galicier L, Coppo P, Marzac C, Aumont C, Lambotte O, et al. Reactive Hemophagocytic Syndrome in Adults: A Retrospective Analysis of 162 Patients. Am J Med. 2014;127(11):1118–25.
– Fardet L, Galicier L, Lambotte O, Marzac C, Aumont C, Chahwan D, et al. Development and Validation of the HScore, a Score for the Diagnosis of Reactive Hemophagocytic Syndrome: Score for Reactive Hemophagocytic Syndrome. Arthritis Rheumatol. 2014;66(9):2613–20.
1 Scott RB, Robb-Smith AH. Histiocytic medullary reticulocytosis. Lancet. 1939;2:194–8.
2 Karras A, Thaunat O, Noël LH, Delahousse M. Syndrome d’activation macrophagique: implications pour le néphrologue. Actualités néphrologiques. 2005;59–80.
3 Meki A, O’Connor D, Roberts C, et al. Hemophagocytic lymphohistiocytosis in chronic lymphocytic leukemia. J Clin Oncol. 2011;29(24):e685–7.
4 Machaczka M, Vaktnäs J, Klimkowska M, Hägglund H Malignancy-associated hemophagocytic lymphohistiocytosis in adults: a retrospective population-based analysis from a single center. Leuk Lymphoma. 2011;52:613–9.
5 Kelesidis T, Humphries R, Terashita D, et al. Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis in Los Angeles County. J Med Virol. 2012;84:777–85.
6 Henter JI, Horne A, Arico M, Egeler RM, Filipovich AH, Imashuku S, et al. HLH-2004: diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis. Pediatr Blood Cancer. 2007;48:124–31.
7 Lykens JE, Terrell CE, Zoller EE, Risma K, Jordan MB. Perforin is a cri-
tical physiologic regulator of T-cell activation. Blood. 2011;118:618–26.
8 Usmani GN, Woda BA, Newburger PE. Advances in understanding the pathogenesis of HLH. British Journal of Haematology. 2013 Jun;161(5):609–22.
9 Behrens EM, Canna SW, Slade K, Rao S, Kreiger PA, Paessler M, et al. Repeated TLR9 stimulation results in macrophage activation syndrome–like disease in mice. Journal of Clinical Investigation. 2011 Jun 1;121(6):2264–77.
10 Krebs P, Crozat K, Popkin D, et al. Disruption of MyD88 signaling suppresses hemophagocytic lymphohistiocytosis in mice. Blood. 2011;117:6582–8.
11 Canna SW, et al. Interferon-gamma mediates anemia but is dispensable for fulminant toll-like receptor 9-induced macrophage activation syndrome and hemophagocytosis in mice. Arthritis Rheum. 2013 Jul;65(7):1764–75.
12 Ramos-Casals M, Brito-Zerón P, López-Guillermo A, Khamashta MA, Bosch X. Adult haemophagocytic syndrome. The Lancet. 2014;383(9927):1503–16.
13 Campo M, Berliner N. Hemophagocytic Lymphohistiocytosis in Adults. Hematology/Oncology Clinics of North America. 2015 Oct;29(5):915–25.
14 Tseng YT, Sheng WH, Lin BH, et al. Causes, clinical symptoms, and outcomes of infectious diseases associated with hemophagocytic lymphohistiocytosis in Taiwanese adults. J Microbiol Immunol Infect. 2011;44:191–7.
15 Rouphael NG, Talati NJ, Vaughan C, Cunningham K, Moreira R, Gould C. Infections associated with haemophagocytic syndrome. The Lancet infectious diseases. 2007;7(12):814–22.
16 Lambotte O, Méchaï F. Syndrome d’activation macrophagique. La Lettre de l’infectiologue [Internet]. 2007;22(3).
17 Karras A, Thervet E, Legendre C, and the Groupe Coopératif de transplantation d’Ile de France. Hemophagocytic syndrome in renal transplant recipients: report of 17 cases and review of literature. Transplantation. 2004;77:238–43.
18 Majluf-Cruz A, Sosa-Camas R, P.rez-Ram.rez O, Rosas-Cabral A, Vargas-Vorackova F, Labardini-M.ndez J. Hemophagocytic syndrome associated with hematological neoplasias. Leuk Res. 1998;22:893–8.
19 Papo T. Syndromes hémophagocytaires, syndrome d’activation des macrophages. EMC-AKOS (Traité de médecine). 2011;1–8. SAM 2.
20 Rivière S, Galicier L, Coppo P, Marzac C, Aumont C, Lambotte O, et al. Reactive Hemophagocytic Syndrome in Adults: A Retrospective Analysis of 162 Patients. The American Journal of Medicine. 2014 Nov;127(11):1118–25.
21 Okamoto M, Yamaguchi H, Isobe Y, Yokose N, Mizuki T, Tajika K, et al. Analysis of triglyceride value in the diagnosis and treatment response of secondary hemophagocytic syndrome. Internal Medicine. 2009;48(10):775–81.
22 Knovich MA, Storey JA, Coff man LG, Torti SV, Torti FM. Ferritin for the clinician. Blood Rev. 2009;23:95–104.
23 Allen CE, Yu X, Kozinetz CA, McClain KL. Highly elevated ferritin levels and the diagnosis of hemophagocytic lymphohistiocytosis. Pediatr Blood Cancer. 2008;50:1227–35.
24 Francois B, Trimoreau F, Vignon P, et al. Thrombocytopenia in the sepsis syndrome: role of hemophagocytosis and macrophage colony-stimulating factor. Am J Med. 1997;103:114–20.
25 Wang Z, Wang Y, Wang J, et al. Early diagnostic value of low percentage of glycosylated ferritin in secondary hemophagocytic lymphohistiocytosis. Int J Hematol. 2009;90:501–5.
26 Schaer DJ, Schleiffenbaum B, Kurrer M, et al. Soluble hemoglobin-haptoglobin scavenger receptor CD163 as a lineage-specific marker in the reactive hemophagocytic syndrome. Eur J Haematol. 2005;74(1):6–10.
27 Imashuku S, Teramura T, Tauchi H, IshidaY, OtohY, Sawada M, et al. Longitudinal follow-up of patients with Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis. Haematologica. 2004;89:183–8.
28 Jordan MB, Allen CE, Weitzman S, et al. How I treat hemophagocytic lymphohistiocytosis. Blood. 2011;118:4041–52.
29 Fardet L, Galicier L, Lambotte O, Marzac C, Aumont C, Chahwan D, et al. Development and Validation of the HScore, a Score for the Diagnosis of Reactive Hemophagocytic Syndrome: Score for Reactive Hemophagocytic Syndrome. Arthritis & Rheumatology. 2014 Sep;66(9):2613–20.
30 Li J, Wang Q, Zheng W, et al. Hemophagocytic lymphohistiocytosis: clinical analysis of 103 adult patients. Medicine 2014;93:100–5.
31 Buyse S, Teixeira L, Galicier L, et al. Critical care management of patients with hemophagocytic lymphohistiocytosis. Intensive Care Med. 2010;36:1695–702.
32 Schram AM, Berliner N. How I treat hemophagocytic lymphohistiocytosis in the adult patient. Blood. 2015;125(19):2908–14.
33 Johnson TS, Terrell CE, Millen SH, Katz JD, Hildeman DA, Jordan MB. Etoposide Selectively Ablates Activated T Cells To Control the Immunoregulatory Disorder Hemophagocytic Lymphohistiocytosis. The Journal of Immunology. 2014 Jan 1;192(1):84–91.
34 Imashuku S, Kuriyama K, Teramura T, et al. Requirement for etoposide in the treatment of Epstein–Barr virus-associated hemophagocytic lymphohistiocytosis. J Clin Oncol 2001;19:2665–73.
35 Galicier L, Ce qu’il faut savoir sur le syndrome d’activation macrophagique aux soins intensifs. Réanimation. 2014;23:482–90.
36 Fukaya S, Yasuda S, Hashimoto T, et al. Clinical features of haemophagocytic syndrome in patients with systemic autoimmune diseases: analysis of 30 cases. Rheumatology (Oxford). 2008;47:1686–91.
37 Larroche C. Hemophagocytic lymphohistiocytosis in adults: Diagnosis and treatment. Joint Bone Spine. 2012 Jul;79(4):356–61.
38 Tothova Z, Berliner N. Hemophagocytic syndrome and critical illness: new insights into diagnosis and management [published online ahead of print January 8, 2014]. J Intensive Care Med. doi:10.1177/0885066613517076.
39 Henter JI, Tondini C, Pritchard J. Histiocyte disorders. Crit Rev Oncol Hematol. 2004;50:157–74.
40 Ravelli A. Macrophage activation syndrome. Curr Opin Rheumatol. 2002;14:548–52.
41 Larroche C, Bruneel F, André MH, et al (2000). [Intravenously administered gamma-globulins in reactive hemaphagocytic syndrome. Multicenter study to assess their importance, by the immunoglobulins group of experts of CEDIT of the AP-HP]. Ann MedInterne (Paris) 151:533–9.
42 Takahashi N, Chubachi A, KumeM, et al. A clinical analysis of 52 adult patients with hemophagocytic syndrome: the prognostic significance of the underlying diseases. Int J Hematol.
2001;74:209–13.
43 Tseng YT, Sheng WH, Lin BH, et al. Causes, clinical symptoms, and outcomes of infectious diseases associated with hemophagocytic lymphohistiocytosis in Taiwanese adults. J Microbiol Immunol Infect. 2011;44(3):191–7.
44 Otrock ZK, Eby CS. Clinical characteristics, prognostic factors, and outcomes of adult patients with hemophagocytic lymphohistiocytosis. Am J Hematol. 2015;90:220–4.
45 Trottestam H, Berglöf E, Horne A, et al. Risk factors for early death in children with haemophagocytic lymphohistiocytosis. Acta Paediatr. 2012;101(3):313–8.
46 Hejblum G, Lambotte O, Galicier L, Coppo P, Marzac C, Aumont C, Fardet L. A web-based delphi study for eliciting helpful criteria in the positive diagnosis of hemophagocytic syndrome in adult patients. PLoS One. 2014;9(4):e94024.